ACM
KDNY

Aquatic Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Aquatic Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,000
Closed -$79K – 1927
2022
Q3 		$79K Buy
+4,000
New +$80.2K 0.01% 818
2022
Q2 		– Sell
-100
Closed -$2K – 1679
2022
Q1 		$2K Sell
100
-900
-90% -$12.2K ﹤0.01% 994
2021
Q4 		$16K Buy
+1,000
New +$14.2K 0.03% 672

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Aquatic Capital Management's KDNY Position: Q4 2022 in Review

Aquatic Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2022, closing a stake of 4,000 shares — an estimated $79K sold.

Aquatic Capital Management first reported a position in KDNY in Q4 2021 and held it in 3 quarters. The position peaked at $79K in Q3 2022. 155 funds tracked by Wall St. Rank hold KDNY as of Q4 2022.

  • Aquatic Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 4,000 Chinook Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $79K.
  • Aquatic Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $79K in Q3 2022.
  • 155 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.